2021-10-01
Bloomberg
TrialSpark, which wants to leverage its clinical trials management software into drug discovery, raised $156M Series C at a $1B+ valuation earlier this year
a sector where productivity is slowing down, and thus the opposite of Moore's Law. Cool idea. Let's hope it works! https://twitter.com/... https://twitter.com/... Sam Altman / @sama : Delighted to fin...
Loading articles...